Literature DB >> 17379082

Relevance and feasibility of multi-parameter assessment for management of mass casualties from a radiological event.

Nicholas Dainiak1, Paul Berger, Joseph Albanese.   

Abstract

OBJECTIVE: Local, regional, and federal response teams play an integrated role in the early management of mass casualties from a radiologic incident. Evaluation of individuals exposed to ionizing radiation requires an assessment of clinical signs and symptoms and an estimation of radiation dose. Here, we determine the relevance and feasibility of multi-parameter assessment for management of mass casualties from a radiological event.
METHOD: An assessment of the value of signs and symptoms and of individual biological dosimetry is made. To determine the feasibility of applying dosimetric data in a mass casualty event, a survey was conducted of the 32 clinical laboratories meeting criteria in the State of Connecticut. Following completion of a training program, a functional drill was conducted to determine efficacy of training and proficiency of sample preparation for the cytogenetic bioassay.
RESULTS: Based upon reliability and timeliness of clinical information and dosimetric data, it is evident that both forms of data should be provided in a mass casualty scenario. A needs assessment of clinical laboratories in Connecticut identified 30 of 32 clinical laboratories that were qualified and willing to perform initial processing of biodosimetry specimens. Currently, 79 laboratory professionals in 19 of the qualified clinical laboratories were trained in specimen processing. Of these individuals, 37 participated in a functional drill that demonstrated an acceptable cell viability (>95%) and turnaround time for samples (199 minutes).
CONCLUSION: Multi-parameter assessment provides useful information to clinicians caring for mass casualties from a radiological event. Assessment of individual radiation dose by the cytogenetic bioassay is made more feasible by building clinical laboratory surge capacity.

Entities:  

Mesh:

Year:  2007        PMID: 17379082     DOI: 10.1016/j.exphem.2007.01.007

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  10 in total

1.  Local, regional and national responses for medical management of a radiological/nuclear incident.

Authors:  Nicholas Dainiak; Beata Skudlarska; Joseph Albanese
Journal:  Dose Response       Date:  2012-10-22       Impact factor: 2.658

Review 2.  Literature review and global consensus on management of acute radiation syndrome affecting nonhematopoietic organ systems.

Authors:  Nicholas Dainiak; Robert Nicolas Gent; Zhanat Carr; Rita Schneider; Judith Bader; Elena Buglova; Nelson Chao; C Norman Coleman; Arnold Ganser; Claude Gorin; Martin Hauer-Jensen; L Andrew Huff; Patricia Lillis-Hearne; Kazuhiko Maekawa; Jeffrey Nemhauser; Ray Powles; Holger Schünemann; Alla Shapiro; Leif Stenke; Nelson Valverde; David Weinstock; Douglas White; Joseph Albanese; Viktor Meineke
Journal:  Disaster Med Public Health Prep       Date:  2011-10-10       Impact factor: 1.385

3.  Serum Amyloid A as a Biomarker for Radiation Exposure.

Authors:  Mary Sproull; Tamalee Kramp; Anita Tandle; Uma Shankavaram; Kevin Camphausen
Journal:  Radiat Res       Date:  2015-06-26       Impact factor: 2.841

Review 4.  Radiologic and nuclear events: contingency planning for hematologists/oncologists.

Authors:  David M Weinstock; Cullen Case; Judith L Bader; Nelson J Chao; C Norman Coleman; Richard J Hatchett; Daniel J Weisdorf; Dennis L Confer
Journal:  Blood       Date:  2008-02-20       Impact factor: 22.113

5.  Diagnosis of partial body radiation exposure in mice using peripheral blood gene expression profiles.

Authors:  Sarah K Meadows; Holly K Dressman; Pamela Daher; Heather Himburg; J Lauren Russell; Phuong Doan; Nelson J Chao; Joseph Lucas; Joseph R Nevins; John P Chute
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

6.  Migration of skin dendritic cells in response to ionizing radiation exposure.

Authors:  Ryan J Cummings; Soumya Mitra; Thomas H Foster; Edith M Lord
Journal:  Radiat Res       Date:  2009-06       Impact factor: 2.841

7.  Antibody-based screen for ionizing radiation-dependent changes in the Mammalian proteome for use in biodosimetry.

Authors:  Richard G Ivey; Oby Subramanian; Travis D Lorentzen; Amanda G Paulovich
Journal:  Radiat Res       Date:  2009-05       Impact factor: 2.841

8.  Urinary miRNAs as Biomarkers for Noninvasive Evaluation of Radiation-Induced Renal Tubular Injury.

Authors:  Sagar Bhayana; Feifei Song; Jidhin Jacob; Paolo Fadda; Nicholas C Denko; Meng Xu-Welliver; Arnab Chakravarti; Naduparambil K Jacob
Journal:  Radiat Res       Date:  2017-10-04       Impact factor: 2.841

9.  Detection of Acute Radiation Sickness: A Feasibility Study in Non-Human Primates Circulating miRNAs for Triage in Radiological Events.

Authors:  Naresh Menon; Claude J Rogers; Agnes I Lukaszewicz; James Axtelle; Marshleen Yadav; Feifei Song; Arnab Chakravarti; Naduparambil K Jacob
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

10.  Correlation of plasma FL expression with bone marrow irradiation dose.

Authors:  Mary Sproull; Dane Avondoglio; Tamalee Kramp; Uma Shankavaram; Kevin Camphausen
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.